Paradigm Biopharmaceuticals Limited
ASX:PAR.AX
0.235 (AUD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||
| Net Income
| -58.653 | -51.91 | -39.25 | -34.297 | -12.299 | -15.628 | -6.19 | -4.275 | -2.924 | -1.565 | -0.231 |
| Depreciation & Amortization
| 0.147 | 0.154 | 0.193 | 0.21 | 0.213 | 0.008 | 0.015 | 0.017 | 0.003 | 0 | 0 |
| Deferred Income Tax
| 0 | 3.741 | 0.234 | -6.422 | -0.93 | -1.245 | 0.139 | 0.306 | 1.283 | 0 | 0 |
| Stock Based Compensation
| 0 | 0.936 | 3.27 | 3.206 | 1.278 | 2.042 | 0.781 | 0.179 | 0.051 | 0.749 | 0 |
| Change In Working Capital
| -8.685 | 5.334 | 4.439 | -3.735 | 0.718 | -0.797 | -0.92 | -0.485 | -1.335 | 0.004 | -0.721 |
| Accounts Receivables
| 1.725 | -0.089 | 1.789 | -4.998 | 0.022 | -0.797 | -0.92 | -0.485 | -1.335 | 0.004 | -0.12 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | -1.08 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -9.34 | 5.073 | 2.102 | 2.202 | 0.751 | 1.126 | 1.082 | 0.274 | 0.669 | 0 | 0 |
| Other Working Capital
| -1.07 | 0.349 | 0.549 | -0.94 | -0.055 | -0.045 | -1.082 | -0.274 | -0.669 | 0 | -0.601 |
| Other Non Cash Items
| 9.155 | -3.441 | -1.093 | 6.109 | 0.93 | 9.254 | 0.161 | 0.094 | 0.618 | -0.391 | 0.334 |
| Operating Cash Flow
| -65.945 | -45.186 | -32.205 | -34.929 | -10.09 | -6.365 | -6.013 | -4.47 | -3.588 | -1.203 | -0.618 |
| Investing Activities: | |||||||||||
| Investments In Property Plant And Equipment
| 0 | 0 | 0 | -0.032 | -0.131 | -0.018 | -0.003 | -0.02 | -0.013 | 0 | 0 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | -6.5 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0.7 | 5.754 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | 0 | 0.699 | 5.75 | -0.004 | -0.012 | -1.902 | -0.753 | -0.238 | -0.51 |
| Investing Cash Flow
| 0 | 0 | 0 | 0.668 | 5.623 | -6.522 | -0.015 | -1.922 | -0.766 | -0.238 | -0.51 |
| Financing Activities: | |||||||||||
| Debt Repayment
| 0 | -0.416 | -0.205 | -0.122 | -0.094 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 28.279 | 62.223 | 0 | 1.124 | 34.251 | 82.778 | 5.884 | 5.985 | 7.369 | 0 | 0 |
| Common Stock Repurchased
| 0 | -3.765 | 0 | 0 | -2.588 | -5.27 | -0.622 | -0.519 | -0.631 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0 | 63.367 | 0.275 | -0 | 7.073 | 5.27 | 0.622 | 0.519 | 0.49 | 1.558 | 1.175 |
| Financing Cash Flow
| 28.177 | 62.535 | 0.07 | 1.003 | 36.053 | 82.778 | 5.884 | 5.985 | 7.227 | 1.558 | 1.175 |
| Other Information: | |||||||||||
| Effect Of Forex Changes On Cash
| 0 | -0.69 | 0.775 | 0.371 | 0 | 0 | 0 | 0 | -0.001 | 0.008 | 0 |
| Net Change In Cash
| -38.512 | 16.659 | -31.361 | -32.887 | 31.586 | 69.891 | -0.145 | -0.408 | 2.873 | 0.125 | 0.047 |
| Cash At End Of Period
| 17.821 | 56.333 | 39.674 | 71.035 | 103.922 | 72.336 | 2.446 | 2.591 | 2.998 | 0.125 | 0.047 |